文献速递血管炎

巨细胞动脉炎患者诊断后一年内的感染风险:抗生素使用与住院情况

The one-year infection risk among patients diagnosed with giant cell arteritis: use of antibiotics and hospitalisations.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

这项全国性观察性队列研究纳入1996-2022年丹麦国家患者登记中年龄≥50岁的17773例新发巨细胞动脉炎(GCA)患者,按1:10匹配一般人群对照,评估诊断后1年感染风险。GCA患者总体感染1年累积发生比例为52.4%,感染相关住院为17.6%,总体感染相对危险度为1.40,感染相关住院为2.71。累积糖皮质激素剂量、高龄(≥70岁)和较高合并症与感染风险增加相关。

要点

  • GCA患者诊断后1年总体感染累积发生比例为52.4%,感染相关住院为17.6%。
  • 与一般人群相比,GCA患者总体感染RR为1.40,感染相关住院RR为2.71。
  • 累积糖皮质激素剂量、高龄(≥70岁)和较高合并症与GCA患者感染风险增加相关。

核心结论

  • GCA诊断后第一年抗生素处方使用和感染相关住院相较于背景人群较高。
  • 累积糖皮质激素剂量与感染风险相关。

研究设计与样本

  • 全国性观察性队列研究,纳入丹麦国家患者登记(1996-2022)中年龄≥50岁、首次诊断为GCA的患者。
  • GCA患者按性别和出生日期以1:10匹配一般人群个体,从诊断日期开始随访。
  • 总体感染定义为 redeemed antibiotic prescriptions 或感染相关住院。
  • 采用伪观察方法评估1年累积发生比例(CIP)、风险差(RD)和相对危险度(RR)。

主要发现

  • 研究纳入17773例新发GCA患者和177730名参考个体。
  • GCA患者1年总体感染CIP为52.4%(95% CI:51.7-53.2),感染相关住院CIP为17.6%(95% CI:17.1-18.2)。
  • 与参考队列相比,GCA患者总体感染RR为1.40(95% CI:1.38-1.42),感染相关住院RR为2.71(95% CI:2.61-2.82)。
  • 在GCA患者中,较高的累积糖皮质激素剂量、高龄(≥70岁)和较高合并症与感染风险增加相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with giant cell arteritis (GCA) primarily have their infections managed by primary care providers and hospitalisation is rarely necessary. Existing studies in GCA focus on infection-related hospitalisations only, whereas the use of antibiotic prescriptions is largely unknown. This study aims to examine the one-year overall infection risk among patients with GCA. METHODS: This nationwide observational cohort study included patients aged ≥50 years with a first-time GCA diagnosis in the Danish National Patient Registry (1996-2022). Patients with GCA were matched 1:10 by sex and date of birth with general population individuals and followed from date of diagnosis. Overall infections were defined as redeemed antibiotic prescriptions or infection-related hospitalisations. Utilising a pseudo-observation approach, we assessed 1-year cumulative incidence proportions (CIP), risk differences (RD) and relative risks (RR) of infections. RESULTS: The study included 17 773 incident patients with GCA and 177 730 reference individuals. Patients with GCA had a 1-year CIP of 52.4% (95% CI: 51.7-53.2) for overall infections and 17.6% (95% CI: 17.1-18.2) for infection-related hospitalisations. Compared with the reference cohort, patients with GCA had a RR of 1.40 (95% CI: 1.38-1.42) for overall infections and 2.71 (95% CI: 2.61-2.82) for infection-related hospitalisations. Additionally, higher cumulative glucocorticoid doses, advanced age (≥70 years) and higher comorbidity were associated with an increased risk of infections among patients with GCA. CONCLUSIONS: The use of antibiotic prescriptions and infection-related hospitalisations in the first year after a GCA diagnosis is high compared with the background population. The cumulative glucocorticoid dose is associated with the infection risk.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Therkildsen P, de Thurah A, Nielsen BD, et al. The one-year infection risk among patients diagnosed with giant cell arteritis: use of antibiotics and hospitalisations. Rheumatology (Oxford). 2025. PMID: 38341668. doi:10.1093/rheumatology/keae107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。